1. Concord Biotech
stock logo

34% Hold

Concord Biotech Share Price

CONCORDBIO

₹1,559.65-₹12.15 (-0.77%) TodayLast updated on 21 Jun, 2024 | 03:55 PM IST
₹1,547.55₹1,595.40
L
Show Current Price
H
  • News

  • Company overview

  • Fundamentals

  • More

Company overview

Financial performance

arrow

Market cap

Market Cap Switch₹16,012 Crs

Open

₹1,574.75

Close

₹1,571.80

Circuit range

₹1,871.55 - ₹1,247.75

Day range

₹1,547.55 - ₹1,595.40

Year range

₹900.05 - ₹1,725.00

Volume

78,790

Avg. traded

₹1,570.52

Revenue (12m)

₹1,017 Crs

Concord BiotechConcord Biotech Limited is an India-based research and development driven biopharma company. The Company is engaged in the research and development, manufacturing, marketing, and selling of pharmaceutical products. The Company manufactures active pharmaceutical ingredients (API) through fermentation and semi-synthetic processes and finished formulations. It manufactures fermentation and semi-synthetic based products in the therapeutic segments, such as immunosuppressants, anti-bacterial, oncology, anti-fungal and others. Its API products include Mycophenolate Mofetil, Mycophenolate Sodium, Cyclosporine, Vancomycin Hydrochloride, Micafungin Sodium, Mupirocin, Romidepsin, Dactinomycin, and Pravastatin Sodium, among others. It also has a pipeline of API products under development. Its API products under development include Polymyxin B, Fidaxomicin, Doxorubicin, and others. The Company provides products in the critical care, immunology, nephrology, and transplant medicine segments.

Concord Biotech Key indicators

arrow

52 week high

₹1,725.00

52 week low

₹900.05

P/E ratio

51.99

P/B ratio

10.49

ROE

21.63%

ROCE

28.89%

Dividend yield

0.56%

Debt/Equity ratio

EPS

29.13

Learn more

Investment checklist: (2/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst ratings:

Hold

arrow

Buy

33%

Hold

34%

Sell

33%

This analysis is based on the reviews of 3 experts in the last 7 days

Fundamentals

Financial ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

45.82%

Net profit margin

29.97%

ROE

21.63%

ROA

18.96%

ROCE

28.89%

Learn more

Concord Biotech Shareholder returns

arrow

1 day

-0.77%

1 week

+7.96%

1 month

+7.44%

3 months

+6.34%

1 year

+65.43%

3 years

+65.43%

5 years

+65.43%

Concord Biotech Share Price history

arrow
DayOpenCloseDay’s change
Fri, Jun 21 2024
₹1,574.75
₹1,559.65
-0.77%
Thu, Jun 20 2024
₹1,576.50
₹1,571.80
-0.26%
Wed, Jun 19 2024
₹1,585.25
₹1,575.90
-0.43%
Tue, Jun 18 2024
₹1,534.90
₹1,582.70
+3.41%
Fri, Jun 14 2024
₹1,444.00
₹1,530.50
+5.94%
Thu, Jun 13 2024
₹1,452.95
₹1,444.70
+0.92%
Wed, Jun 12 2024
₹1,449.45
₹1,431.55
-1.20%
Tue, Jun 11 2024
₹1,445.00
₹1,448.95
+0.08%

Shareholding info

arrow

Promoters (44.08%)

Mutual Funds (5.15%)

Retail and other (41.03%)

Foreign institutions-FII (6.49%)

Other domestic institutions (3.25%)

Promoters

Learn more

More

Frequently asked questions